Suppliers / North China Pharmaceutical

North China Pharmaceutical

China 274 employees 5 duplicate records merged Updated 9 July 2026

The public registers hold a second record for North China Pharmaceutical. The fuller profile, with 9 active US DMFs and 5 valid CEPs, is at North China Pharmaceutical. Figures on this page cover only this record.

North China Pharmaceutical is a finished-dose manufacturer based in China. It appears in 236 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with INHRR (VE), MINSA (CR) and EFDA (ET). Its GMP standing is certified by MFDS (Korea), INVIMA (CO) and ANVISA (Brazil).

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
236
filings across 9 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
HEBEI, China Not on file
China, China 3038207912
Shijiazhuang, Colombia Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
INHRR (VE) 151 None
MINSA (CR) 26 None
EFDA (ET) 15 None
ARCSA (EC) 14 None
ZAMRA (ZM) 10 None
NAFDAC (NG) 10 None
MFDS (Korea) None 2
INVIMA (CO) None 1
ANVISA (Brazil) None 1

Questions about North China Pharmaceutical

Does North China Pharmaceutical hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for North China Pharmaceutical. It does have 236 filings with 9 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is North China Pharmaceutical FDA-registered?
One site operated by North China Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does North China Pharmaceutical manufacture?
3 registered sites are on record, in China and Colombia (Hebei, China and Shijiazhuang). Every site is listed on this page with the register it came from.
Which regulators recognise North China Pharmaceutical's GMP?
Current GMP certificates are on record from MFDS (Korea), INVIMA (CO) and ANVISA (Brazil). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. North China Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Astrazeneca Pharmaceutical also in China Changzhou Syntheall Pharmaceutical also in China Changzhou Yinsheng Pharmaceutical also in China Chengdu Shuode Pharmaceutical also in China Chia Tai Tianqing Pharmaceutical Group also in China

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates